ArticleHuman mutation2026

Convergent Immune-Coagulation Programs Underlie Gastrointestinal Bleeding Risk in Portal Vein Tumor Thrombosis-Associated Hepatocellular Carcinoma and Portal Hypertension.

Xu Rutao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.